Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness and Risks of Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole: a Randomised Placebo-controlled Multi-centre Clinical Trial

NCT04965298 is registered in ClinicalTrials.gov with Norfolk and Norwich University Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT04965298
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04965298 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness and Risks of Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole: a Randomised Placebo-controlled Multi-centre Clinical Trial
Lead sponsor
Norfolk and Norwich University Hospitals NHS Foundation Trust
Phase
Phase 3
Overall status
Recruiting
Start date
June 16, 2021
Completion date
February 28, 2026
Enrollment
298 (estimated)
Sites
57

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic pulmonary fibrosis